2,063
Views
1
CrossRef citations to date
0
Altmetric
Nephrology & Urology

Emergency decompression for patients with ureteral stones and SIRS: a prospective randomized clinical study

, , &
Pages 965-972 | Received 06 Sep 2022, Accepted 11 Jan 2023, Published online: 07 Mar 2023

References

  • Wagenlehner FM, Pilatz A, Weidner W. Urosepsis–from the view of the urologist. Int J Antimicrob Agents. 2011;38 Suppl(Suppl):51–57.
  • Kozyrakis D, Kratiras Z, Soukias G, et al. Clinical outcome and prognostic factors of sepsis, septic shock and prolonged hospitalization, of patients presented with acute obstructive pyelonephritis. J Endourol. 2020;34(4):516–522.
  • Tambo M, Okegawa T, Shishido T, et al. Predictors of septic shock in obstructive acute pyelonephritis. World J Urol. 2014;32(3):803–811.
  • Anıl H, Şener NC, Karamık K, et al. Comparison of percutaneous nephrostomy and ureteral DJ stent in patients with obstructive pyelonephritis: a retrospective cohort study. J Invest Surg. 2022;35(7):1445–1450.
  • de Sousa Morais N, Pereira JP, Mota P, et al. Percutaneous nephrostomy vs ureteral stent for hydronephrosis secondary to ureteric calculi: impact on spontaneous stone passage and health-related quality of life-a prospective study. Urolithiasis. 2019;47(6):567–573.
  • Xu ZH, Yang YH, Zhou S, et al. Percutaneous nephrostomy versus retrograde ureteral stent for acute upper urinary tract obstruction with urosepsis. J Infect Chemother. 2021;27(2):323–328.
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810.
  • Pietropaolo A, Hendry J, Kyriakides R, et al. Outcomes of elective ureteroscopy for ureteric stones in patients with prior urosepsis and emergency drainage: prospective study over 5 yr from a tertiary endourology centre. Eur Urol Focus. 2020;6(1):151–156.
  • Blackwell RH, Barton GJ, Kothari AN, et al. Early Intervention during acute stone admissions: revealing “the weekend effect” in urological practice. J Urol. 2016;196(1):124–130.
  • Nishiguchi S, Branch J, Suganami Y, et al. Effectiveness of early ureteric stenting for urosepsis associated with urinary tract calculi. Intern Med. 2014;53(19):2205–2210.
  • Mokhmalji H, Braun PM, Martinez Portillo FJ, et al. Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: a prospective, randomized clinical trial. J Urol. 2001;165(4):1088–1092.
  • Flukes S, Hayne D, Kuan M, et al. Retrograde ureteric stent insertion in the management of infected obstructed kidneys. BJU Int. 2015;115(Suppl 5):31–34.
  • Yoshimura K, Utsunomiya N, Ichioka K, et al. Emergency drainage for urosepsis associated with upper urinary tract calculi. J Urol. 2005;173(2):458–462.
  • Kranz J, Stangl F, Kuppe C, et al. Urosepsis – sicher diagnostizieren und effektiv behandeln! [Urosepsis-targeted diagnostics and effective therapy]. Urologie. 2022;61(6):596–601. doi:10.1007/s00120-022-01832-5
  • Hsu SL, Fan CK, Liu HY. Obstructive hydronephrosis with secondary urosepsis. Clin Case Rep. 2022;10(4):e05689.
  • Cao JD, Wang ZC, Wang YL, et al. Risk factors for progression of urolith associated with obstructive urosepsis to severe sepsis or septic shock. BMC Urol. 2022;22(1):46.
  • Sheng Y, Zheng WL, Shi QF, et al. Clinical characteristics and prognosis in patients with urosepsis from intensive care unit in Shanghai, China: a retrospective bi-centre study. BMC Anesthesiol. 2021;21(1):296.
  • van Nieuwkoop C, Bonten TN, Van’t Wout JW, et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care. 2010;14(6): r 206.
  • Zheng J, Li Q, Fu W, et al. Procalcitonin as an early diagnostic and monitoring tool in urosepsis following percutaneous nephrolithotomy. Urolithiasis. 2015;43(1):41–47.
  • Cui N, Yu Z, Chen Z, et al. Research on the correlation of serum PCT and plasma GSN levels with the prognosis of urosepsis patients. Pak J Med Sci. 2020;36(5):1011–1014. doi:10.12669/pjms.36.5.2143
  • Yoder IC, Lindfors KK, Pfister RC. Diagnosis and treatment of pyonephrosis. Radiol Clin North Am. 1984;22(2):407–414.
  • Boeri L, Fulgheri I, Palmisano F, et al. Hounsfield unit attenuation value can differentiate pyonephrosis from hydronephrosis and predict septic complications in patients with obstructive uropathy. Sci Rep. 2020;10(1):18546. doi:10.1038/s41598-020-75672-8
  • Huang YY, Alleyne A, Leung V, et al. Urosepsis due to extended-spectrum β-lactamase-producing Escherichia coli: a retrospective, single-centre review of risk factors and clinical outcomes. Can J Hosp Pharm. 2018;71(2):119–127.
  • Shafi H, Shahandeh Z, Heidari B, et al. Bacteriological study and structural composition of staghorn stones removed by the anatrophic nephrolithotomic procedure. Saudi J Kidney Dis Transpl. 2013;24(2):418–423.
  • Patodia M, Goel A, Singh V, et al. Are there any predictors of pyonephrosis in patients with renal calculus disease?. Urolithiasis. 2017;45(4):415–420. doi:10.1007/s00240-016-0933-2
  • Liu J, Zhou C, Gao W, et al. Does preoperative urine culture still play a role in predicting post-PCNL SIRS? A retrospective cohort study. Urolithiasis. 2020;48(3):251–256. doi:10.1007/s00240-019-01148-8
  • Covino M, Manno A, Merra G, et al. Reduced utility of early procalcitonin and blood culture determination in patients with febrile urinary tract infections in the emergency department. Intern Emerg Med. 2020;15(1):119–125.